National Cancer Institute (NCI) Grants $26.3 Million to Help Establish Seven Centers of Cancer Nanotechnology Excellence (CCNEs)
In the NCIâ€™s first phase of its $144.3 million five-year initiative for cancer nanotechnology research, it has awarded just over $26 million dollars to seven Centers of Cancer Nanotechnology Excellence (CCNEs). The CCNEs are multi-institutional programs that will focus on the integration of nanotechnology into both basic and applied research, as well as search for new solutions for the diagnosis and treatment of cancer. The CCNEs are associated with one or more NCI-designated Cancer Centers, are affiliated with schools of physical or engineering sciences, and have non-profit and/or private sector companies as partners; these partnerships help to advance the technologies to be developed. U.S. states to receive a NCI grant in this first round include: California (2), Georgia, Illinois, Massachusetts, Missouri, and North Carolina. The NCI, a division of the National Institutes of Health (NIH), formed the NCI Alliance for Nanotechnology in Cancer last September as an initiative to develop and convert cancer-related nanotechnology research into medical practice. The NCI and other organizations believe nanotechnology shows strong potential in cancer research and treatment.